Stay updated with breaking news from Advantaged. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LEAWOOD, KS / ACCESSWIRE / December 2, 2022 / To assist our shareholders with year-end planning, we are providing estimates of the per-share special distribution to be paid in December to satisfy the Fund's
Party that— than stage right. now you have a party that seems to be returning to what theresa may wants called "the nasty— what theresa may wants called "the nasty pa rty" what theresa may wants called "the nasty party" that they are only speaking — nasty party" that they are only speaking to people who they think will vote _ speaking to people who they think will vote for them. the impression they give _ will vote for them. the impression they give is— will vote for them. the impression they give is they don't care about people _ they give is they don't care about people who won't vot...
Once we've gone over the grieving for this moment. king charles is taking over at a time, you know, when this country have a lot of problem. maybe not as bad as it was in the immediate post-war year, but the nation is quite divided. and economical crisis. and he has made it his job through his work as prince of wales to try to help people who are less advantaged in our society. and i suspect that when we hear from him in a couple of hours time, that may be part of his message, that he wants to unite people. so we kind of have to move on from national grieving. we heard keir talking about it. i...
Is still showing remarkable protection against severe disease and death by the vaccines. we have to keep looking. we don't know whether that protection will wane. and i think what some governments are doing is looking at this question of, well, maybe the vaccine protection will wane over the course of this coming winter, and we ought to, as a cautious approach to give a third dose now to make sure that doesn't happen. but as i say, we have no evidence scientifically at the moment that that's needed. and it does deny people in other countries getting that dose. let's end where we began, with yo...
Stephen Sackur speaks to Professor Sir Andrew Pollard, a key player in the development of the Oxford AstraZeneca Covid-19 vaccine.